Litcius/Paper detail

Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies

Qi Lin, Holly Lindsay, Mari Kogiso, Yuchen Du, Frank Braun, Huiyuan Zhang, Lei Guo, Sibo Zhao, Sarah G. Injac, Patricia Baxter, Jack Su, Sophie Xiao, Stephen W. Erickson, Eric J. Earley, Beverly A. Teicher, Malcolm A. Smith, Xiao‐Nan Li

2021Laboratory Investigation26 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMedulloblastomaCisplatinPharmacologyEZH2In vivoCancerInternal medicineOncologyCancer researchChemotherapyEpigeneticsBiologyBiochemistryGeneChemistryBiotechnologyGlioma Diagnosis and TreatmentEpigenetics and DNA MethylationRenal and related cancers
Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies | Litcius